an injectable form of ARSENIC called Trisenox

Oncologists are now using an injectable form of ARSENIC called Trisenox.

Trisenox (arsenic trioxide) is for second-line therapy of acute promyelocytic leukemia.

It's very effective...up to 70% remission in patients who don't do well on standard chemotherapy.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote